Yon Seth D 4

What Happened

• Yon Seth D, Chief Executive Officer of Sanara MedTech, was granted 25,430 restricted shares on 2026-03-22. The award was recorded at $0 per share (total reported value $0) as a compensation grant rather than an open-market purchase or sale. The shares are subject to a time-based vesting schedule.

Key Details

• Transaction date: 2026-03-22; Form filed: 2026-03-23 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares granted: 25,430; price per share: $0; total dollar value reported: $0.
• Vesting: Shares vest in three equal installments — one-third on March 22 of 2027, 2028 and 2029 — contingent on continued employment (see footnote F1).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: Grant made under Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan; vesting conditioned on employment through each vest date.

Context

• Restricted stock grants are compensation/retention awards that vest over time; they are not the same as open-market purchases and do not by themselves indicate a near-term buy/sell signal. Vesting conditions mean the shares generally cannot be sold until they vest (or unless specific plan provisions apply).